project id: TCGA-LIHC; case submitter id: TCGA-BC-A8YO; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.45; rna integrity number: 9.3; age at index: 66; days to birth: -24189; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1947; age at diagnosis: 24189; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 562.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 141; days to sample procurement: 0; initial weight: 680.0; portion submitter id: TCGA-BC-A8YO-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 3.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 17.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;